Silent Embolism during TAVR: Just Images or Potential Cognitive Deterioration?

Finding new cerebral ischemic imaging after transcatheter aortic valve replacement (TAVR) is almost the rule, especially for self-expandable valves. These images might disappear over the months but, unfortunately, they are associated to small but significative cognitive deterioration. 

Embolia silente durante el TAVI ¿solo imágenes o pueden deteriorar la cognición?

Most patients undergoing TAVR develop silent cerebral ischemic lesions (SCILs) that show in magnetic resonance imaging (MRI). The natural history of this images and their potential clinical implications were not well established in the literature. 

This study included 117 patients with baseline MRI within 7 days before TAVR and age-related white matter change score. 

After procedure, a new MRI was done to assess occurrence, localization, number and dimension of the new ischemic lesions. Patients with new lesions repeated the MRI at 3 to 5 months followup. 

In addition to MRIs, neurocognitive tests were carried out prior procedure, at discharge and at 3-month followup. 

There were new ischemic lesions in 76% of patients, distributed across all territories: a median number of 2, median diameter 4.5 mm and median total volume 140 mm³.

Independent predictors of these images were greater baseline age-related white matter deterioration and the use of self-expandable valves.  


Read also: Post TAVR Acute Coronary Syndrome: Frequency and Potential Damage.


The third MRI showed only 26.7% of patients evolved with a post procedure gliotic scar in lieu of ischemic lesions. 

After procedure, there was transient neurocognitive deterioration in all patients, but this was far more pronounced in patients with new ischemic lesions. Also, recovery was slower when there were new ischemic lesions. 

Conclusion

Silent ischemic lesions were observed in most patients undergoing TAVR. Most of these lesions can disappear over time, but they have significant cognitive impact. 

Original Title: Evolution, Predictors, and Neurocognitive Effects of Silent Cerebral Embolism During Transcatheter Aortic Valve Replacement.

Reference: Marco De Carlo et al. J Am Coll Cardiol Intv 2020, article in press. https://doi.org/10.1016/j.jcin.2020.03.004.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...